Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Histology and Histopathology|February 27, 2025
Genomic features of bladder neuroendocrine carcinoma with composite histologyAkihiro Ohmoto, Keiichiro Kitahama, Yasuyuki Shigematsu, et al.
Oncotarget|September 20, 2019
Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinomaAkihiro Ohmoto, Masami Suzuki, Erina Takai, et al.
Oncotarget|May 17, 2018
Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinomaAkihiro Ohmoto, Masami Suzuki, Erina Takai, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2024
Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paragangliomaAkihiro Ohmoto, Yasuyuki Shigematsu, Rumiko Saito, et al.
Molecular and Clinical Oncology|September 21, 2020
An extragonadal germ cell tumor with dermatomyositis: A case report and literature reviewYu Fujiwara, Naoki Fukuda, Akihiro Ohmoto, et al.
BMC Cancer|April 24, 2025
Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinomaKeiichiro Kitahama, Yasuyuki Shigematsu, Emiko Sugawara, et al.
In Vivo (Athens, Greece)|March 1, 2020
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With LenvatinibNaoki Fukuda, Xiaofei Wang, Akihiro Ohmoto, et al.
Journal of Gastroenterology|April 19, 2018
Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelinesAkihiro Ohmoto, Chigusa Morizane, Emi Kubo, et al.
In Vivo (Athens, Greece)|February 24, 2021
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck CancerYasuyoshi Sato, Naoki Fukuda, Y U Fujiwara, et al.
Pageof 7